Latest News
Pan-emerging markets private equity firm Actis has appointed Arjun Oberoi as global healthcare sector head and Ivy Santoso as Indonesian country head.
Oberoi will head Actis’s global healthcare sector, an area of increasing interest for the firm as an ageing population, changes in lifestyle, increasing income, and better insurance coverage continue to drive demand for high quality medical products and services across emerging markets.
Actis’s current healthcare investments include hospital chain Sterling Add-Life, clinical research organisation Veeda, healthcare IT provider Anthelio, and the largest local player in the Chinese endoscopy consumable sector, Nanjing Micro-Tech.
Santoso will be Actis country
Edmond de Rothschild Investment Partners, which has just celebrated its 10th anniversary, has revealed plans to raise EUR500m over the next four years and increase net asset under management to EUR1.3bn.
Edmond de Rothschild Investment Partners currently manages EUR1bn focusing on growth capital and life sciences in France and Europe.
Despite a difficult environment since 2008, institutional and private investors have continued to support the teams in successfully raising three funds: BioDiscovery 3, Winch 2 and Cabestan. BioDiscovery 4 is also expected to reach its EUR200m target very soon.
Edmond de Rothschild Investment Partners aims to raise EUR500m over the
Purchasing Platform, a Chicago-based procurement company focused on the real estate industry, has closed an angel round of investment capital.
The company raised a total of USD565,000 from various angel investors and intends to use the investment to fund start-up operations and complete the development of its ecommerce platform.
The Purchasing Platform application is a membership-based website aggregating the buying power of real estate operators to provide a centralised vehicle for the purchasing needs of both property managers and corporate staff. With more than 15 years of commercial real estate experience, the company’s founder and chief executive Peter Hepner identified
P&P Water Holdings (Greece), an affiliate of Paine & Partners Capital Fund III, has completed the acquisition of majority ownership of Eurodrip, a manufacturer and supplier of drip irrigation solutions.
As part of the investment, which was previously announced in October 2012, Water Holdings purchased all of the shares of Eurodrip currently held by Aquanova International Holdings, a company controlled by Global Capital Investors II, a private equity fund advised exclusively by Global Finance, as well as Bellaria Holding, which together represent approximately 67.5 per cent of the company’s outstanding shares, for a price of EUR1.53 per share.
In addition,
Panoramic Growth Equity’s renewable energy distribution specialist business, Solfex Energy Systems, has been sold to Travis Perkins.
The sale represents the first exit from the Panoramic Enterprise Capital Fund I, which held its final close in September 2010 and was oversubscribed at GBP34m.
The sale has generated an IRR of 62 per cent for Panoramic, in just 16 months since it invested GBP1.25m into the business in September 2011. This return is expected to increase to an IRR of 120 per cent following the earn out period. With Panoramic’s backing Solfex has seen its profitability increase substantially and turnover
The European Bank for Reconstruction and Development (EBRD) has launched a USD1bn seven-year global bond issue, the borrower’s first ever benchmark offering in this maturity.
This transaction responds to global investor demand for the highest quality fixed-income investments, against the continued overall flight to quality and the backdrop of appetite for yield and widening swap spreads at the time of announcing the trade.
Demand for the triple-A borrower’s latest issue was significant at the indicated price of five basis points above mid-swaps, with no pushback on level from accounts. This enabled EBRD to price its deal flat to Asian Development
Merger and acquisition (M&A) activity in the US oil and gas industry hit a 10-year high during the fourth quarter of 2012 with 75 deals, according to PwC US.
A number of factors drove this activity, including private equity (PE) interest, foreign buyers, shale plays, and companies looking to get deals done before the end of the year with the looming fiscal cliff and proposed tax changes.
In fact, that flurry of fourth quarter activity pushed overall deal volume in 2012 to a 10-year high at 204 transactions (for deals valued at over USD50m), representing USD146.2bn – the second highest
SB Israel Telecom, an affiliate of Saban Capital Group, has closed its purchase of the controlling interest in Partner Communications Company from Scailex Corporation.
Partner, a provider of communications services in Israel, including cellular, internet and fixed telephony, operates the orange and 012 Smile brands in Israel.
The transaction includes the assumption of debt owed by Scailex to Advent Investments, a subsidiary of Hutchison Whampoa.
Haim Saban, chairman and chief executive officer of Saban Capital Group, says: “We have great confidence in the Israeli economy and we are very impressed with the quality of management, entrepreneurial spirit and strength of
Oceans Healthcare, Louisiana’s largest provider of psychiatric facilities for geriatric patients, has closed a USD17m round of strategic growth equity financing from General Catalyst Partners.
The financing will be used to capitalise the organisation as a foundation for its geographic expansion.
As part of the transformation, Charlie Baker, former chief executive of Harvard Pilgrim Healthcare, one of the country’s top-rated health benefits companies, will join Oceans as chairman of the board.
David Fialkow, Brian Shortsleeve, Gabe Ling, and Charlie Baker, all of General Catalyst Partners, will join Oceans’ board of directors. Co-founders Jason Reed and Nick Guillory, founded Oceans in
Unilever Ventures has sold its stake in BAC to Nasdaq-listed Life Technologies, which had revenues of USD3.7bn in 2011, in a deal advised on by mid-market advisory firm Clearwater Corporate Finance.
Netherlands-based BAC specialises in the discovery, development and manufacture of protein purification products. The company has been acquired by global biotechnology business Life Technologies for an undisclosed sum.
The acquisition will expand Life Technologies’ capabilities and product offering in the growing market of biopharmaceutical research and manufacturing.
The team at Clearwater comprised partner Philip Nuttall and senior healthcare analyst Ramesh Jassal, with support of director Nick Horrocks,
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
